Go to:
Logótipo
Comuta visibilidade da coluna esquerda
Você está em: Start > Publications > View > Cytotoxicity of the serotonergic drug 1-(1-naphthyl) piperazine in human MNT-1 melanoma cells
Publication

Publications

Cytotoxicity of the serotonergic drug 1-(1-naphthyl) piperazine in human MNT-1 melanoma cells

Title
Cytotoxicity of the serotonergic drug 1-(1-naphthyl) piperazine in human MNT-1 melanoma cells
Type
Other Publications
Year
2015
Authors
Menezes, AC
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Ferreira de Oliveira, JPF
(Author)
FCUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Carvalheiro, M
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Oliveira, H
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Ascenso, A
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Other information
Authenticus ID: P-00K-ABC
Language: English
Type (Professor's evaluation): Scientific
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same authors

Cytotoxic effect of the serotonergic drug 1-(1-Naphthyl)piperazine against melanoma cells (2018)
Article in International Scientific Journal
Menezes, AC; Carvalheiro, M; de Oliveira, JMPF; Ascenso, A; Oliveira, H
Recommend this page Top
Copyright 1996-2025 © Faculdade de Direito da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2025-08-07 at 02:56:44 | Privacy Policy | Personal Data Protection Policy | Whistleblowing